Discovery of a novel tetrapeptide as glucose homeostasis modulator with bifunctionalities of targeting DPP-IV and microbiota

References

[1] Wong, Nathan D., and Naveed Sattar. 2023. “Cardiovascular Risk in Diabetes Mellitus: Epidemiology, Assessment and Prevention.” Nature Reviews Cardiology 20: 685-695. https://doi.org/10.1038/s41569-023-00877-z

[2] Mohan, Viswanathan. 2023. “National Diabetes Prevention Programmes in LMICs Are Now a Necessity.” Lancet Global Health 11: e1480-e1481. https://doi.org/10.1016/s2214-109x(23)00381-9

[3] Nongonierma, Alice B., and Richard J. FitzGerald. 2019. “Features of Dipeptidyl Peptidase IV (DPP-IV) Inhibitory Peptides From Dietary Proteins.” Journal of Food Biochemistry 43: e12451. https://doi.org/10.1111/jfbc.12451

[4] Daroit, Daniel Joner, and Adriano Brandelli. 2021. “In Vivo Bioactivities of Food Protein-Derived Peptides - A Current Review.” Current Opinion in Food Science 39: 120-129. https://doi.org/10.1016/j.cofs.2021.01.002

[5] Tu, Maolin, Shuzhen Cheng, Weihong Lu, and Ming Du. 2018. “Advancement and Prospects of Bioinformatics Analysis for Studying Bioactive Peptides From Food-Derived Protein: Sequence, Structure, and Functions.” TrAC Trends in Analytical Chemistry 105: 7-17. https://doi.org/10.1016/j.trac.2018.04.005

[6] Guan, Changge, Jiawei Luo, Shucheng Li, Zhenglin Tan, Yi Wang, Haihong Chen, Naoyuki Yamamoto, et al. 2023. “Exploration of DPP-IV Inhibitory Peptide Design Rules Assisted by the Deep Learning Pipeline That Identifies the Restriction Enzyme Cutting Site.” ACS Omega 8: 39662-39672. https://doi.org/10.1021/acsomega.3c05571

[7] Chen, Haihong, Bing Xu, Yi Wang, Wei Li, Dong He, Yan Zhang, Xizhen Zhang, and Xinhui Xing. 2023. “Emerging Natural Hemp Seed Proteins and Their Functions for Nutraceutical Applications.” Food Science and Human Wellness 12: 929-941. https://doi.org/10.1016/j.fshw.2022.10.016

[8] Chen, Haihong, Wei Li, Yi Wang, Bing Xu, Xi Hu, Xiaobing Li, Junyu Liu, et al. 2023. “Mining and Validation of Novel Hemp Seed-Derived DPP-IV-Inhibiting Peptides Using a Combination of Multi-Omics and Molecular Docking.” Journal of Agricultural and Food Chemistry 71: 9164-9174. https://doi.org/10.1021/acs.jafc.3c00535

[9] Nie, Qixing, Haihong Chen, Jielun Hu, Songtao Fan, and Shaoping Nie. 2019. “Dietary Compounds and Traditional Chinese Medicine Ameliorate Type 2 Diabetes by Modulating Gut Microbiota.” Critical Reviews in Food Science and Nutrition 59: 848-863. https://doi.org/10.1080/10408398.2018.1536646

[10] Nie, Qixing, Jielun Hu, He Gao, Linlin Fan, Haihong Chen, and Shaoping Nie. 2019. “Polysaccharide From Plantago Asiatica L. Attenuates Hyperglycemia, Hyperlipidemia and Affects Colon Microbiota in Type 2 Diabetic Rats.” Food Hydrocolloids 86: 34-42. https://doi.org/10.1016/j.foodhyd.2017.12.026

[11] Nie, Qixing, Xi Luo, Kai Wang, Yong Ding, Shumi Jia, Qixiang Zhao, Meng Li, et al. 2024. “Gut Symbionts Alleviate MASH Through a Secondary Bile Acid Biosynthetic Pathway.” Cell 187: 2717-2734.e33. https://doi.org/10.1016/j.cell.2024.03.034

[12] Dhar, Hena, Subhash Verma, Sarita Dogra, Shailja Katoch, Rishika Vij, Geetanjali Singh, and Mandeep Sharma. 2024. “Functional Attributes of Bioactive Peptides of Bovine Milk Origin and Application of In Silico Approaches for Peptide Prediction and Functional Annotations.” Critical Reviews in Food Science and Nutrition 64: 9432-9454. https://doi.org/10.1080/10408398.2023.2212803

[13] Liu, Rui, Jianming Cheng, and Hao Wu. 2019. “Discovery of Food-Derived Dipeptidyl Peptidase IV Inhibitory Peptides: A Review.” International Journal of Molecular Sciences 20: 463. https://doi.org/10.3390/ijms20030463

[14] Nabeno, Mika, Fumihiko Akahoshi, Hiroyuki Kishida, Ikuko Miyaguchi, Yoshihito Tanaka, Shinichi Ishii, and Takashi Kadowaki. 2013. “A Comparative Study of the Binding Modes of Recently Launched Dipeptidyl Peptidase IV Inhibitors in the Active Site.” Biochemical and Biophysical Research Communications 434: 191-196. https://doi.org/10.1016/j.bbrc.2013.03.010

[15] Lee, Young Hee, Hee Won Lee, and Hyung Jin Choi. 2017. “GLP-1 Based Combination Therapy for Obesity and Diabetes.” Journal of Obesity & Metabolic Syndrome 26: 155-160. https://doi.org/10.7570/jomes.2017.26.3.155

[16] Nie, Qixing, Yonggan Sun, Wenbing Hu, Chunhua Chen, Qiongni Lin, and Shaoping Nie. 2024. “Glucomannan Promotes Bacteroides Ovatus to Improve Intestinal Barrier Function and Ameliorate Insulin Resistance.” iMeta 3: e163. https://doi.org/10.1002/imt2.163

[17] Sun, Yonggan, Qixing Nie, Shanshan Zhang, Huijun He, Sheng Zuo, Chunhua Chen, Jingrui Yang, et al. 2023. “Parabacteroides Distasonis Ameliorates Insulin Resistance via Activation of Intestinal GPR109a.” Nature Communications 14: 7740. https://doi.org/10.1038/s41467-023-43622-3

[18] Cani, Patrice D., Clara Depommier, Muriel Derrien, Amandine Everard, and Willem M. de Vos. 2022. “Akkermansia Muciniphila: Paradigm for Next-Generation Beneficial Microorganisms.” Nature Reviews Gastroenterology & Hepatology 19: 625-637. https://doi.org/10.1038/s41575-022-00631-9

[19] Sauvage, Eric, Frédéric Kerff, Mohammed Terrak, Juan A. Ayala, and Paulette Charlier. 2008. “The Penicillin-Binding Proteins: Structure and Role in Peptidoglycan Biosynthesis.” FEMS Microbiology Reviews 32: 234-258. https://doi.org/10.1111/j.1574-6976.2008.00105.x

RIGHTS & PERMISSIONS

2025 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.